Evidence map›Paper›PMID 36288342›Full record

ArticlePloS one2022

Infection with SARS-CoV-2 is associated with menstrual irregularities among women of reproductive age.

Emily M Cherenack, Ana S Salazar, Nicholas F Nogueira, Patricia Raccamarich, Violeta J Rodriguez, Alejandro M Mantero, Allison Marsh, Sophia Gerard, Marissa Maddalon, Deborah L Jones and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Host factors of SARS-CoV-2 in infection, pathogenesis, and long-term effects.Frontiers in cellular and infection microbiology · 2024
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Emily M CherenackDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0002-8762-2050
Ana S SalazarDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0001-5617-5609
Nicholas F NogueiraDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0002-8973-5454
Patricia RaccamarichDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Violeta J RodriguezDepartment of Psychology, University of Georgia, Athens, Georgia, United States of America.
Alejandro M ManteroDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Allison MarshDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0003-1623-7857
Sophia GerardDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Marissa MaddalonDepartment of Medicine, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Deborah L JonesDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.
Nichole R KlattDepartment of Surgery, University of Minnesota Medical School, Minneapolis, Minnesota, United States of America.
Maria L AlcaideDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, United States of America.ORCID 0000-0003-4648-0145
University of Miami · USUniversity of Minnesota · US

Funding

University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALLAN E RODRIGUEZ · 2007 to 2026
$33.8M
University of Miami Developmental HIV/AIDS Mental Health Research Center (D-ARC)P30MH116867 · NIMH · UNIVERSITY OF MIAMI CORAL GABLES · PI SAFREN, STEVEN A · 2019 to 2023
$6.5M
Mechanisms underlying recurrent bacterial vaginosis and HIV risk A Multidisciplinary approachR01AI138718 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ALCAIDE, MARIA LUISA · 2018 to 2023
$3.5M
Syndemics, the microbiome, and mucosal inflammation involved in HIV acquisitionF32AI162229 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI CHERENACK, EMILY MELLISSA · 2021 to 2023
$211k
Revision and Validation of the Multidimensional Assessment of Parenting Scale (MAPS) in a Racially and Ethnically Diverse National SampleR36MH127838 · NIMH · UNIVERSITY OF GEORGIA · PI RODRIGUEZ, VIOLETA DE JESUS · 2021 to 2022
$86k
NIAID NIH HHS F32 AI162229NIAID NIH HHS P30 AI073961NIAID NIH HHS R01 AI138718NIMH NIH HHS P30 MH116867NIMH NIH HHS R36 MH127838
6 · The paper itself

Abstract

backgroundBiological and psychological mechanisms may be responsible for menstrual irregularities occurring among women during the COVID-19 pandemic. STUDY

designFrom January 2019 to September 2021, women (18- to 45-years-old and not using hormonal contraception) were recruited in Miami-Dade County, Florida. Cross-sectional, self-report surveys collected data on menstrual irregularities, COVID-19 vaccination, stress, depression, and loneliness. A EUA approved rapid test assay using whole blood measured SARS-CoV-2 IgG antibodies. Chi-square and Fisher's exact tests described menstrual irregularities among women recruited before versus after the start of the COVID-19 pandemic and with detectable versus undetectable SARS-CoV-2 IgG antibodies. A logistic regression examined the relationship between the presence of SARS-CoV-2 IgG antibodies and menstrual irregularities controlling for age, stress, depression, and loneliness.

resultsAmong 182 women enrolled, 73 were enrolled after pandemic onset, and 36 provided vaccination data. Having detectable SARS-CoV-2 IgG antibodies was associated with a higher percentage of menstrual irregularities among unvaccinated women (0% vs. 39%, p = .026) and among all women regardless of vaccination status (31% vs. 5%; p = .005). Adjusting for age and psychological variables, the odds of menstrual irregularities were 7.03 times (95% CI [1.39, 35.60]; p = .019) higher among women with detectable antibodies compared to women without detectable antibodies. Neither enrollment date, age, nor psychological factors were associated to menstrual irregularities.

conclusionsBiological mechanisms related to SARS-CoV-2 infection may be responsible for irregular menstruation and should be further examined to mitigate the impact of the COVID-19 pandemic on women's health.

Indexed as

COVID-19SARS-CoV-2AdolescentAdultAntibodies, ViralCOVID-19 VaccinesCross-Sectional StudiesFemaleHumansImmunoglobulin GMenstruation DisturbancesMiddle AgedPandemicsYoung AdultAntibodies, ViralCOVID-19 VaccinesImmunoglobulin G

Identifiers

PMID36288342
PMCPMC9604006
OpenAlexW4307309177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.